MRC2CD147TNF-αHFDMASLD

Hui-Ru Kuo1,2, Kwei-Yan Liu2, Hsin-Ying Clair Chiou3,4

  • 1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

概括

巨细胞上的C2型曼诺糖受体 (MRC2) 通过激活CD147信号和TNF-α释放,促进代谢功能障碍相关的脂肪性肝病 (MASLD). 缺乏MRC2可缓解肝脏肥胖和炎症,这表明MRC2是MASLD的治疗点.